创业家·2026-02-02 10:30Core Viewpoint - The article discusses the dramatic decline of Zhifei Biological Products Co., Ltd., a leading vaccine manufacturer in China, and the subsequent shift in wealth dynamics in Chongqing, highlighting the fall of the Jiang Rensheng family from the top of the wealth hierarchy due to significant financial losses and the rise of new business leaders in the region [4][5][19]. Group 1: Company Performance and Financial Decline - Zhifei Biological announced a projected net loss of 10.698 billion to 13.726 billion yuan for 2025, representing a year-on-year decline of 630% to 780% [4][5]. - The company's revenue in 2023 reached 52.92 billion yuan, with a net profit of 7.915 billion yuan, but the revenue is expected to plummet to 26.07 billion yuan in 2024, a nearly 75% decrease [14]. - The reliance on agency business for 88.84% of total revenue has left Zhifei vulnerable, leading to a severe profitability crisis as market conditions shifted [14][25]. Group 2: Wealth Dynamics and Family Impact - The Jiang Rensheng family's wealth has decreased from 140 billion yuan in 2021 to 42 billion yuan in 2025, a loss of nearly 100 billion yuan, equivalent to the combined market value of two leading listed companies in Chongqing [16]. - The stock market valuation of Zhifei Biological has dropped from 360 billion yuan to 41 billion yuan, exacerbating liquidity and asset impairment pressures [16]. - The family is now resorting to asset pledges and loans to manage financial strain, marking a significant shift from their previous status as a dominant business family [18][19]. Group 3: Market Competition and Industry Trends - The vaccine industry is experiencing intensified competition as domestic vaccine manufacturers improve their R&D capabilities, leading to a breakdown of foreign monopolies [25]. - The introduction of domestic HPV vaccines has triggered price wars, significantly impacting Zhifei's market position and profitability [13][25]. - The article emphasizes the need for companies to transition from reliance on external resources to developing core technologies to survive in a changing market landscape [26].